Trial Profile
An investigator initiated 15 year follow up study of OM-MUC-1 in breast cancer patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs OM-MUC 1 (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 05 Nov 2015 New trial record